Recipient
Spartan Bioscience Inc.Department
National Research Council CanadaAmount
$687.9K
Province
ONType
Contribution
Agreement Number
172-2019-2020-Q4-947397
Purpose
Spartan Bioscience (Spartan) proposes development of a SARS-CoV-2 assay to operate on its Cube sample-to-result real-time PCR testing platform. The proposed assay will have a simple workflow requiring no sample preparation after sample collection. The portable size of the Cube, along with the simplicity of the proposed workflow allows the solution to be deployed and implemented into airports, border crossings, and critical national infrastructure with ease.
Spartan Bioscience Inc. × National Research Council Canada
6 grants totalling $2.4M
Industrial Research Assistance Program – Contributions to Firms
1,000 grants totalling $112.4M
Related Grants
| Recipient | Amount | Program |
|---|---|---|
| Providence Therapeutics Holdings Inc. | $10.0M | Industrial Research Assistance Program –... |
| Entos Pharmaceuticals Inc. | $10.0M | Industrial Research Assistance Program –... |
| Entos Pharmaceuticals Inc. | $10.0M | Industrial Research Assistance Program –... |
| Laurent Pharmaceuticals Inc. | $10.0M | Industrial Research Assistance Program –... |
| Laurent Pharmaceuticals Inc. | $10.0M | Industrial Research Assistance Program –... |